Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD
Public ClinicalTrials.gov record NCT03247517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of SPN 812 (Viloxazine Extended-release Capsule) 200 and 400 mg Efficacy and Safety in Adolescents With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Study identification
- NCT ID
- NCT03247517
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Supernus Pharmaceuticals, Inc.
- Industry
- Enrollment
- 310 participants
Conditions and interventions
Conditions
Interventions
- 200mg SPN-812 Drug
- 400mg SPN-812 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2017
- Primary completion
- Oct 16, 2018
- Completion
- Oct 16, 2018
- Last update posted
- Jun 17, 2021
2017 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research | Dothan | Alabama | 36303 | — |
| Neuropsychiatric Research Center of Orange County | Orange | California | 92868 | — |
| Indago Research & Health Center, Inc. | Hialeah | Florida | 33012 | — |
| Clinical Neuroscience Solutions, Inc | Jacksonville | Florida | 32217 | — |
| Miami Clinical Research | Miami | Florida | 33155 | — |
| Advanced Clinical Research | Meridian | Idaho | 83642 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| Texas Physicians Medical Research Group | Arlington | Texas | 76014 | — |
| Houston Clinical Trials | Houston | Texas | 77098 | — |
| Family Psychiatry of the Woodlands | The Woodlands | Texas | 77381 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03247517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2021 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03247517 live on ClinicalTrials.gov.